TommyBoyTrader

[train21]

$TONR MOVING

[seventhcircle]

$NXGB only 10mm unrestricted shares news this morning https://finance.yahoo.com/news/nxgen-brands-inc-sets-date-123000795.html

[glenn1919]

IFBD.....BURU.....https://stockcharts.com/h-sc/ui?s=IFBD&p=W&b=5&g=0&id=p84354014936
https://stockcharts.com/h-sc/ui?s=BURU&p=W&b=5&g=0&id=p84354014936

[ProfitScout]

$SRM Entertainment Showcases New Products at the 2024 Las Vegas Winter Market Gift Show

January 28th - February 1st Showroom C972, C975

JUPITER, FL, Jan. 29, 2024 (GLOBE NEWSWIRE) -- SRM Entertainment, Inc., (Nasdaq: SRM) (the “Company” or “SRM”) will introduce a new line of products at the iconic Winter Market 2024 in Las Vegas from January 28 through February 1st, featuring our new Zoo Animals assortment, Sealife assortment and custom designs.

The SRM Design Team’s creativity will be featured as we showcase our custom design capabilites and introduce our new Zoo Animals and Sealife poduct assortment lines at the Las Vegas Market Winter Show, a leading industry trade show (Showroom C972 & C975).

"The Las Vegas Market is the perfect West Coast venue to feature the creativity and experience of the SRM Team" said Rich Miller, CEO of SRM Entertainment. “We’re excited to showcase new products and design innovations that feature SRM’s imaginitive capabilities for 2024 and beyond.”

About SRM Entertainment, Inc.

SRM Entertainment, Inc. designs, develops and manufactures custom toys and souvenirs for the world's largest theme parks and entertainment venues. The Company provides exclusive custom products that are available worldwide at venues such as Walt Disney Parks and Resorts, Universal Studios, SeaWorld and other attractions. Additionally, SRM recently launched its retail product line which includes patented SMURFS Sip with Me cups.

Caution Regarding Forward-Looking Statements

Certain statements in this announcement are forward-looking statements. Investors can identify these forward-looking statements by words or phrases such as “may,” “will,” “expect,” “anticipate,” “aim,” “estimate,” “intend,” “plan,” “believe,” “is/are likely to,” “potential,” “continue” or other similar expressions. These statements are subject to uncertainties and risks including, but not limited to, the risk factors discussed in the “Risk Factors” section of the registration statement for the Offering filed with the SEC. Although the Company believes that the expectations expressed in these forward-looking statements are reasonable, it cannot assure you that such expectations will turn out to be correct, and the Company cautions investors that actual results may differ materially from the anticipated results and encourages investors to review other factors that may affect its future results in the Company's registration statement and other filings with the SEC. Additional factors are discussed in the Company's filings with the SEC, which are available for review at www.sec.gov. The Company undertakes no obligation to update or revise publicly any forward-looking statements to reflect subsequent occurring events or circumstances, or changes in its expectations that arise after the date hereof, except as may be required by law.

Media and Investor Relations

[e-mail]
(407)-230-8100
website: SRMentertainment.com

https://www.globenewswire.com/newsroom/ti?nf=OTAyNjY3NyM2MDQxNDA0IzUwMDExODAxNA==
https://ml.globenewswire.com/media/ZTQzZTQ4ZTQtN2U3NS00MTE4LWFiODUtZTRmNzg3ZjIzNWU2LTUwMDExODAxNA==/tiny/SRM-Entertainment-Inc-.png

Source: SRM Entertainment, Inc.

[glenn1919]

CELU......SNOA.....................https://stockcharts.com/h-sc/ui?s=SNOA
https://stockcharts.com/h-sc/ui?s=CELU

[glenn1919]

TAOP.......CNXA.......RVSN.......MULN.......https://stockcharts.com/h-sc/ui?s=MULN

https://stockcharts.com/h-sc/ui?s=RVSN
https://stockcharts.com/h-sc/ui?s=CNXA
https://stockcharts.com/h-sc/ui?s=TAOP

[johnny smartask]

You're welcome 👍️

[powerbattles]

Thank you. I just fix it and Sorry for the typo it's EMGE

[johnny smartask]

Cant find that ticker ... ENGE ??

[powerbattles]

$EMGE Pending Merger - Acquisition - Exciting Spin-off IPO...

Anyone who has traded 000's for a while knows that it's super rare to find a company poised for massive growth. Emergent Health Reports Quarter over Quarter Revenue Increase of Over 2300%". This unique opportunity extends to the company's small share structure, boasting a market capitalization of only 490k. As of 01/30/2024, the outstanding shares (o/s) stand at 426 million, with 134 million restricted 292 unrestricted, and merely 220 million held at DTC. There has been no toxic dilution, as both the float and outstanding shares have remained unchanged for the past 9 months. This combination of impressive revenue potential, a compact share structure, and a lack of dilution positions this company as a compelling prospect for those seeking a promising investment opportunity and a potential bull run in 2024.

It's Official: Former L'Oreal President Jim Morrison Is Now Emergent Health Corporations. He's the CEO and transitioning to the role of Chairman of the Board at Emergent. Morrison has had a legendary career including numerous leadership positions in the personal care industry, most notably as President of L'Oréal. While at L'Oréal, Morrison oversaw growth that averaged more than 20% year-over-year. He engineered the acquisitions of Redken and Matrix and led the company during a period of unprecedented growth during his tenure.

L'Oréal S.A. is a French personal care company headquartered in Clichy, Hauts-de-Seine, with a registered office in Paris. It is the world's largest cosmetics company As of January 24, 2024, the stock price of L’Oreal SA is 429.0 EUR. The company has a market capitalization of 228.06 billion USD https://www.lorealparisusa.com/ https://www.loreal.com/en/

Emergent the company has the following subsidiaries
https://emergenthealthcompany.com/

1 - Emergent Medical Foods, Inc., a Wyoming corporation incorporated on April 4, 2019,

2 - Emergent OTC Products, Inc., a Wyoming corporation incorporated on August 1, 2019,

3 - PharmaZu, Inc., a Florida corporation incorporated on December 28, 2021.

4 - The Company acquired the assets and certain liabilities of Regen Biowellness, Inc. on August 2, 2022,

5 - Evolutionary Biologics, Inc., a Delaware corporation, acquired on August 15, 2022

Recent Events
MERGER Agreement and SPIN-OFF of PHARMAZU

Apollo Merger Agreement. We have entered into a Plan and Agreement of Merger (the Merger Agreement) with Apollo Biowellness, Inc., a Delaware corporation (Apollo). Our management has determined that there is no impediment to our closing the Merger Agreement. Previously the Company had announced its intention to sell Evolutionary Biologics, Inc., one of its subsidiaries, to Apollo. That transaction has been abandoned, and the Company instead chose to acquire and merge with Apollo

"As part of the roll-up being conducted by Boustead and Apollo Biowellness, effective June 1, 2023, Mr. Morrison will take over as President/CEO of Apollo Biowellness." From my point of view, Morrison taking over as President/CEO of Apollo Biowellness is a positive move. Transitioning to the role of Chairman of the Board at Emergent, his dual involvement with both companies positions him perfectly to coordinate with Boustead moving forward.

HUGE MERGER WITH APOLLO BIOWELLNESS INC.

https://apollobiowellness.com/

The New APOLLO BioWellness Inc.

(Formerly EMERGENT HEALTH COMPANY)

The Future of Regenerative Health

The New APOLLO BioWellness Inc. owns FIVE SUBSIDIARIES:

https://evolutionarybiologics.com/

https://integrativepracticesolutions.com/

https://apollobiowellness.com/wholistic/

https://juventix.com/

https://apollobiowellness.com/maximus/



Upcoming SPIN-OFF PharmaZu IPO that will be applied for listing on NASDAQ or NYSE/AMEX, with NO DILUTION to the Emergent Shareholders.

Emergent Health to spin out subsidiary PharmaZu to its Shareholders pursuant to an IPO underwritten by a Nationally Recognized Investment Banking Firm

Emergent Health Corp. (OTC: EMGE), a curator, developer, and marketer of products in the Regenerative Health Space announced today that it has executed a Term Sheet for a firm committed underwriting with a nationally recognized investment banking firm for $10,000,000 with respect to planned corporate financing transactions, including the private placement of securities (“pre-IPO Financings”) and the planned $10 million initial public offering of Emergent subsidiary PharmaZu common stock (“IPO”) that will be applied for listing on NASDAQ or NYSE/AMEX, with NO DILUTION to Emergent shareholders. PharmaZu is a pure play, e-commerce products and service provider focused on the Pet Community, Pet Pharmacy and Pet Wellness using Influencers and their content, including pet pharmacy, vet telehealth and pet wellness businesses. Upon the effectiveness of the IPO and listing on a national exchange, PharmaZu plans to acquire a 48-state authorized compounding pharmacy located in West Palm Beach, FL, doing approximately $10M a year in revenue, which will serve as the backbone and fulfilment center for PharmaZu, creating a national platform throughout the United States. Subsequently, Emergent plans to distribute to its shareholders, pro rata, the shares of PharmaZu as a dividend, when a record date is set.

MERGER IT'S OFFICIAL: Filing Name Changed Emergent Health Corp To Apollo Biowellness, Inc. According to the filings stated below, the R/S is no longer in effect after September 30, 2023.



ACQUISITION

In December 2023, we entered into a non-binding letter of intent (the “LOI”)
with Accredited Solutions, Inc., a publicly-traded company (symbol: ASII). The LOI
contemplates a sale of certain of our assets, including Evolutionary Biologics, Inc., Nanostehic,
Inc., Nanogistics, Inc., and the brand Maximus Men's Health to ASII, in exchange for a new
class of preferred stock of ASII that would equate to an equity ownership of not less than 80% of
ASII. The corporate structure of the proposed transaction and other relevant terms have not yet
been finalized. The LOI contemplates that the transaction would close early in the first quarter of
2024. However, there is no guarantee that such will be the case

This acquisition is highly favorable. We sell them the asset, and in return, we gain not less than 80% full control of their company. Just think about it—we haven't sold or lost anything in the process. That is the power of negotiation.

I think this news is well worth checking out.
BioRestorative Therapies Enters into Supply Agreement with Evolutionary Biologics.
https://www.globenewswire.com/en/news-release/2023/09/12/2741711/0/en/BioRestorative-Therapies-Enters-into-Supply-Agreement-with-Evolutionary-Biologics.html

Jim Morrison, Chief Executive Officer of Evolutionary Biologics, a division of Emergent Health Corp, (EMGE) stated “we are very excited to be working with Biorestorative Therapies. They are a world class manufacturer of biological products, and operate a state-of-the-art Laboratory and manufacturing facility. This partnership will undoubtedly provide Evolutionary Biologics with a competitive advantage in the large and fast-growing biologics cosmetic marketplace".

Keep in mind “BioRestorative”, “BRTX” or the “Company”) (NASDAQ: BRTX ) "Founded in 2020 by former L'Oreal President, Jim Morrison. Evolutionary Biologics is a supplier of cosmetic-focused biologics for plastic surgeons, dermatologists and medical spas across the United States.

Mr. Morrison is a legend in the personal care industry, most notably as President of L'Oréal. While at L'Oréal, Morrison oversaw growth that averaged more than 20% year-over-year. He engineered the acquisitions of Redken and Matrix and led the company during a period of unprecedented growth during his tenure. He is considered one of the top brand strategists in the personal care space. Morrison has had a long history of working with celebrities in the beauty space, such as Britney Spears, Kimora Lee Simmons, Flo Rida, Katharine McPhee, Christie Brinkley, Rob Lowe, Kylie Jenner, and others.
Business Week Magazine previously wrote: "Over the last two decades, Mr. Morrison has had a profound impact on the American Beauty Industry. In the industry's history, no other executive has had the level of financial responsibility or breadth of organizational experience as Jim. His devotion to, and success within the American Beauty Industry is unmatched."

Unlock all the news:
https://www.marketscreener.com/quote/stock/EMERGENT-HEALTH-CORP-120790864/news/

This stock remains undiscovered by the masses. Additionally, very few are aware that the reverse split (r/s) is no longer in effect after September 30, 2023. I see extremely great value in the current situation. The merger is in progress, as of now, the name change has occurred, but the merger's official closure has not been announced. Typically, mergers and IPO spin-offs trigger a substantial increase in share prices. In this case, the merger will lead to the spin-off of Pharmazu, and shareholders will receive dividends in the form of an IPO. It's rare to encounter an opportunity to capture both a merger and an IPO. As per the news, the initial public offering of Emergent subsidiary PharmaZu common stock ("IPO") is set to be listed on NASDAQ or NYSE/AMEX, with no dilution for Emergent shareholders.

This is the end of part one. For part two I will offer an in-depth analysis of the management team, highlighting both their strengths and weaknesses. In part three, I'll uncover essential aspects like company revenue, services, patents, products, and market share. Stay tuned for a comprehensive examination that goes beyond the surface, covering every facet of this investment opportunity.

All of my posts reflect my personal opinions only. Please refrain from making any buying or selling decisions regarding securities based on my posts. I am not a financial advisor; you are the only one responsible for your trades and investment decisions! I do not receive any form of compensation, whether in cash or shares, from any company or third party mentioned in my posts.

[QuicKtip]

Spectral AI Ltd (NASDAQ:MDAI) founder and CEO Wensheng Fan speaks to Thomas Warner from Proactive after the medical-focused artificial intelligence company announced it has been awarded a new contract valued at up to $149 million by the Biomedical Advanced Research and Development Authority (BARDA), part of the Administration for Strategic Preparedness and Response (ASPR) within the U.S. Department of Health and Human Services.

[deri21]

$INBS Fingerprint Drug Test Delivers Quantifiable Benefits for Customers as Adoption in Workplaces Accelerates
https://www.globenewswire.com/news-release/2024/01/30/2820001/0/en/Fingerprint-Drug-Test-Delivers-Quantifiable-Benefits-for-Customers-as-Adoption-in-Workplaces-Accelerates.html

[CK-verse]

$HHSE NEWS: Hannover House forms InteliMation AI for first major A.I. Animated Feature Production

Press Release | 09/15/2023

(Click on links to view photos)

https://www.accesswire.com/784381/hannover-house-forms-intelimation-ai-for-first-major-ai-animated-feature-production

https://www.otcmarkets.com/stock/HHSE/news/Hannover-House-forms-InteliMation-AI-for-first-major-AI-Animated-Feature-Production?id=414306

JOURNEY TO UTOPIA to begin production in December with A-List Voice & Music Talent

Major launch planned for Cannes and Summer (2024) Theatrical Release
NEW YORK, NY / ACCESSWIRE / September 15, 2023 / InteliMation AI, a newly formed division of indie studio Hannover House, Inc. (OTC PINK:HHSE), has secured a private investment commitment to produce the world's first fully A.I. and CGI generated feature film, the family appeal fantasy film, "Journey to Utopia." Featuring a voice talent cast of Academy Award winning actors and box office stars, the film's visuals will be fully generated using cutting-edge Artificial Intelligence visual rendering, based on producer-supplied scene structure input and character designs.

Director ERIC PARKINSON is targeting a trio of Academy Award winning actors for "JOURNEY TO UTOPIA" - the first-ever fully AI and CGI generated animated feature film. Pictured above: SHIRLEY MACLAINE, FOREST WHITAKER, KIM BASINGER and director ERIC PARKINSON."We have been trying to produce this film for the past ten years," said Eric Parkinson, C.E.O. of Hannover House. "But the visual demands of creating the land of Utopia made the production costs prohibitive and financially risky. That has changed now with the new A.I. technology and our improved strategy to make the film animated as opposed to live-action," he concluded.
"The Artificial Intelligence CGI technology has reached a point where we can create an animated feature that is visually comparable to a $200-million-dollar studio production, but completed for a fraction of the cost and time," said Parkinson. "From script to theatrical DCP, we can produce a major studio quality animated feature in less than eight months."

"The technology from InteliMation should herald in a major paradigm shift in entertainment," said Christian Large, an independent producer and advisor to Hannover House. "High-end animated features will no longer take multiple years and hundreds-of-millions of dollars to produce. This technological breakthrough will enable a broader range of stories to be created and released, which ultimately will help expand the market," he concluded.

The script for "JOURNEY TO UTOPIA" was written by Mike Snyder ("Wildfire") based on a story by Eric Parkinson. The production is in negotiations to secure three Academy Award winning actors as voice talent for the film. Shirley MacLaine is pegged for the role of "Mother Goose;" Forest Whitaker is being pursued to portray the principal antagonist, "Valkerna," and Kim Basinger is being pursued in the role of "Connie Hammonds," the mother of one of the kids who becomes trapped in the land of Utopia.
Pending receipt of a Screen Actors Guild waiver for the production, recording of voice talent is expected to start in late November or early December. A promo reel is planned for the Cannes 2024 festival with a USA Theatrical launch targeted for July 2024.

The world animation market will generate over $411-billion dollars in 2023, according to Statista Research Department - and is expected to grow to over $580-billion by the year 2030. The A.I. fueled software technology pioneered by Hannover House and InteliMation will revolutionize how animated features and television programming are made.

Hannover House and InteliMation are targeting to complete two animated features in 2024, with three set for 2025 and four features per year beginning in 2026. Hannover House will handle the sales representation of the films worldwide, and will coordinate North American theatrical and ancillary sales campaigns with exhibitors, partner studios and major video-on-demand platforms. Hannover House was formed in 1993 and has found success in a variety of indie film distribution arenas, from DVD and VOD distribution to theatrical exhibition.

The release plans for "Journey To Utopia" will follow a traditional model of a wide USA theatrical launch, followed by Video-On-Demand and physical goods (DVDs / BluRay units).

About Eric Parkinson and Hannover House

Eric Parkinson is an indie film distribution veteran of over thirty-five years, best known for his long reigns as CEO of both Hannover House, Inc. and Hemdale Communications. Parkinson has been directly involved with the release of more than 1,500 feature titles, including notable release campaigns for commercial hits including "Terminator," "Highlander 2" and Best Picture Oscar winners "Platoon" and "The Last Emperor." Animated features distributed by Parkinson include three #1 Billboard Magazine Top Selling hits, "Little Nemo: Adventures in Slumberland", "The Magic Voyage" and "The Princess and the Goblin." On the production side, Parkinson has over fifty feature film credits as a Producer or Executive Producer, and just completed his directorial debut with "WILDFIRE: The Legend of the Cherokee Ghost Horse," starring Anne Heche in her final feature release. Hannover House was formed in 1993 as a book publisher, but grew into a top ten Walmart DVD supplier by the mid ‘2000's with dozens of indie releases populating the popular DVD Budget Bins nationwide. The company expanded into theatrical releases, which were a transitional business model to service the growing Video-On-Demand market. Hannover House stopped representing third-party / indie films in 2018 in favor of a business model that focuses resources on the creation of original, high-profile feature productions.

[CK-verse]

$HHSE BLOG: Good Business Math: How to turn $4-mm in Private Investment & Presales into a $100-MM Revenue Stream


Friday, September 15, 2023

(Click on link to view photos)


http://hannoverhousemovies.blogspot.com/2023/09/good-business-math-how-to-turn-4-mm-in.html



Greetings HHSE Friends & Followers - We cannot stress how material and monumental the news of today is: that we are going to be the FIRST production company to make a fully CGI - Artifical Intelligence generated animated feature with JOURNEY TO UTOPIA.

For decades, Disney, Pixar, Fox and Universal / Amblin have controlled the $400+BILLION annual world animation market - due to the obstacles of the HUGE production costs and multi-year schedules that animated features have traditionally required. That all goes away with the advent of Ultra-HD quality AI generated animation, following top-shelf character designs, scene structures and built atop a solid script with Academy Award level voice actors.

Suddenly, a (currently) small company like Hannover House (and our new INTELIMATION AI division) can produce a film that looks and feels comparable to the top studio releases.

But we can do it for $4-million and finish it in less than 8-months. Best of all, the production costs are fully covered by production incentives, bank gap credit and private investors... so HHSE does not have to struggle to find capital or dilute the company's share structure with stock issuances.

This is a seminal moment in the company, and one that will be further enhanced by our uplist filings and the MyFlix division.



Get ready, friends. It's going to be an exciting ride!




Hannover House forms InteliMation AI for first major A.I. Animated Feature Production



JOURNEY TO UTOPIA to begin production in December with A-List Voice & Music Talent

Major launch planned for Cannes and Summer (2024) Theatrical Release



New York, NY - InteliMation AI, a newly formed division of indie studio Hannover House, Inc. (OTC: HHSE), has secured a private investment commitment to produce the world’s first fully A.I. and CGI generated feature film, the family appeal fantasy film, “Journey to Utopia.” Featuring a voice talent cast of Academy Award winning actors and box office stars, the film’s visuals will be fully generated using cutting-edge Artificial Intelligence visual rendering, based on producer-supplied scene structure input and character designs.



“We have been trying to produce this film for the past ten years,” said Eric Parkinson, C.E.O. of Hannover House. “But the visual demands of creating the land of Utopia made the production costs prohibitive and financially risky. That has changed now with the new A.I. technology and our improved strategy to make the film animated as opposed to live-action,” he concluded.



“The Artificial Intelligence CGI technology has reached a point where we can create an animated feature that is visually comparable to a $200-million-dollar studio production, but completed for a fraction of the cost and time,” said Parkinson. “From script to theatrical DCP, we can produce a major studio quality animated feature in less than eight months.”



“The technology from InteliMation should herald in a major paradigm shift in entertainment,” said Christian Large, an independent producer and advisor to Hannover House. “High-end animated features will no longer take multiple years and hundreds-of-millions of dollars to produce. This technological breakthrough will enable a broader range of stories to be created and released, which ultimately will help expand the market,” he concluded.



The script for “JOURNEY TO UTOPIA” was written by Mike Snyder (“Wildfire”) based on a story by Eric Parkinson. The production is in negotiations to secure three Academy Award winning actors as voice talent for the film. Shirley MacLaine is pegged for the role of “Mother Goose;” Forest Whitaker is being pursued to portray the principal antagonist, “Valkerna,” and Kim Basinger is being pursued in the role of “Connie Hammonds,” the mother of one of the kids who becomes trapped in the land of Utopia.



Pending receipt of a Screen Actors Guild waiver for the production, recording of voice talent is expected to start in late November. A promo reel is planned for the Cannes 2024 festival with a USA Theatrical launch targeted for July 2024.

The world animation market will generate over $411-billion dollars in 2023, according to Statista Research Department – and is expected to grow to over $580-billion by the year 2030. The A.I. fueled software technology pioneered by Hannover House and InteliMation will revolutionize how animated features and television programming are made.



Hannover House and InteliMation are targeting to complete two animated features in 2024, with three set for 2025 and four features per year beginning in 2026. Hannover House will handle the sales representation of the films worldwide, and will coordinate North American theatrical and ancillary sales campaigns with exhibitors, partner studios and major video-on-demand platforms. Hannover House was formed in 1993 and has found success in a variety of indie film distribution arenas, from DVD and VOD distribution to theatrical exhibition.



The release plans for “Journey To Utopia” will follow a traditional model of a wide USA theatrical launch, followed by Video-On-Demand and physical goods (DVDs / BluRay units).



About Eric Parkinson and Hannover House

Eric Parkinson is an indie film distribution veteran of over thirty-five years, best known for his long reigns as CEO of both Hannover House, Inc. and Hemdale Communications. Parkinson has been directly involved with the release of more than 1,500 feature titles, including notable release campaigns for commercial hits including “Terminator,” “Highlander 2” and Best Picture Oscar winners “Platoon” and “The Last Emperor.” Animated features distributed by Parkinson include three #1 Billboard Magazine Top Selling hits, “Little Nemo: Adventures in Slumberland”, “The Magic Voyage” and “The Princess and the Goblin.” On the production side, Parkinson has over fifty feature film credits as a Producer or Executive Producer, and just completed his directorial debut with “WILDFIRE: The Legend of the Cherokee Ghost Horse,” starring Anne Heche in her final feature release. Hannover House was formed in 1993 as a book publisher, but grew into a top ten Walmart DVD supplier by the mid ‘2000’s with dozens of indie releases populating the popular DVD Budget Bins nationwide. The company expanded into theatrical releases, which were a transitional business model to service the growing Video-On-Demand market. Hannover House stopped representing third-party / indie films in 2018 in favor of a business model that focuses resources on the creation of original, high-profile feature productions.

[CK-verse]

$HHSE NEWS: Expanded Release Opportunities Push WILDFIRE Theatrical Launch to April 19

Press Release | 01/25/2024

https://www.otcmarkets.com/stock/HHSE/news/Expanded-Release-Opportunities-Push-WILDFIRE-Theatrical-Launch-to-April-19?id=428374

Favorable response from exhibitors, preview audiences and cross-promotional partners has encouraged indie distributor Hannover House, Inc. (OTC: HHSE) to significantly expand the theatrical release for its first fully-facilitated feature production, "WILDFIRE: The Legend of the Cherokee Ghost Horse." The family-appeal movie was inspired by the # 1 worldwide hit song by Michael Martin Murphey, and features the final big-screen performance for the late Anne Heche.


The film was originally slated for a key market theatrical release on Jan. 26, 2024. However, competitive factors and positive audience response have created the opportunity for a wider theatrical break. The release date of April 19 will provide Hannover House with another three-months of pre-release marketing, as well as place the title in a rare calendar window in which no other family appeal releases are scheduled as competition. There are two other wide release films set for April 19: the Guy Ritchie World War II action film, "The Ministry of Ungentlemanly Warfare" from Lionsgate and "Abigail" a horror-thriller from Universal. There are no live-action family features in the weeks leading up to and following April 19, with only two animated releases set as potential competition for family viewers: Disney's "Luca" on March 22, and Viva's "Dragonkeeper" on April 5.


In addition to traditional in-theatre promotions, Hannover House will also be working with a large assortment of local, regional and national cross-promotional sponsors, ranging from rodeo and horse-riding groups to a major, national retail clothing chain.
"Murphey's 'WILDFIRE' song is so iconic and beloved," said Eric Parkinson. "We have seen how cross-generations react to this movie and to the story of a young girl who befriends a mysterious, wild horse. It's got a great message and is a wholesome, family-appeal movie that leaves you with a smile. The opportunity to fit the movie's release into a window in which there are no competitive family titles was a blessing for the movie and for families that love inspirational films," he continued.


Chevel Shepherd, winner of NBC's "The Voice" competition portrays Samantha Nichols, a young girl who is struggling to deal with the sudden loss of her parents. Michael Martin Murphey portrays Pastor Micah, and Mo Brings Plenty ("Yellowstone") plays Udeli, a Cherokee Spiritual Advisor. The parents are played by Adrian Paul ("Highlander") and Cara Jade Myers ("Killers of the Flower Moon"). Other notable cast members include Olivia Slatton-Fite as Joyce, Thesa Loving as Grandma Bette, Major Dodge Senior as Fred and the late, screen legend Anne Heche as the rodeo trainer.


The film was produced by Snowy Morning, Inc., and shot primarily in eastern Oklahoma, with creative guidance and advisors from the United Keetowah Band of Cherokee Indians. Financing was provided through private investors and through facilitation loans made by Hannover House, in consideration for sales representation rights. Eric Parkinson and Mike Snyder wrote the screenplay and Parkinson directed the film.


In addition to the film's national theatrical release on April 19, 2024 Hannover House is working with Cinemark Theatres for a series of "sneak-peek" / word-of-mouth events to occur on February 28 in selected markets.


TITLE LISTING INFORMATION

Title: WILDFIRE: The Legend of the Cherokee Ghost Horse

Genre: Family / Horses / Live-Action

Writers: Written by ERIC PARKINSON and MIKE SNYDER, based on the hit song by MICHAEL MARTIN MURPHEY

Director: ERIC PARKINSON

Producers: CHRIS LARGE, KYLE MARTENS, ERIC PARKINSON

Stars: CHEVEL SHEPHERD, ANNE HECHE, ADRIAN PAULMICHAEL MARTIN MURPHEY, MO BRINGS PLENTY,OLIVIA SLATTON-FITE, THESA LOVING, MAJOR DODGE, SNR., CASSIE SELF and CARA JADE MYERS.

Director of Photography: ANDREW PARKE

Editor: ANDREW BOWCOCK

Running Time: 111 Minutes
MPAA Rating: Pending (anticipate PG)
Format: 1:185 / Dolby Stereo


For More Information Contact: ERIC PARKINSON, 818-481-5277

[glenn1919]

MULN.............................................https://stockcharts.com/h-sc/ui?s=MULN&p=D&yr=0&mn=3&dy=0&id=p11960084343

[QuicKtip]

$MDAI Spectral AI announces "single largest contract to date" https://www.reddit.com/r/10xPennyStocks/comments/1ae38cl/mdai_spectral_ai_announces_single_largest/

[Impacto]

HLYK down big on no news!

[Impacto]

HLYK oversold look at the chart!

[glenn1919]

SLNA.......RNXT.......VLCN.......MULN........https://stockcharts.com/h-sc/ui?s=MULN

https://stockcharts.com/h-sc/ui?s=VLCN
https://stockcharts.com/h-sc/ui?s=RNXT
https://stockcharts.com/h-sc/ui?s=SLNA

[ProfitScout]

$GEMZ News: GEMXX Forecasts Robust Growth Amidst Surging Demand for Ammolite Jewelry and Gold

LAS VEGAS, Jan. 23, 2024 (GLOBE NEWSWIRE) -- via IBN -- GEMXX Corporation ( OTC: GEMZ ) ("GEMXX" or the "Company"), a leading provider of exquisite gemstone jewelry and mine-to-market gold producer anticipates significant growth over the next 24 months. The Company is strategically positioned to capitalize on the burgeoning demand for ammolite jewelry and the sustained upward trajectory in gold prices.

Ammolite

With ammolite becoming the official gemstone of Canada, it has rapidly gained recognition as a rare gemstone, becoming desirable around the world for its unique history and rich colors. The gemstone’s vibrant colors and limited availability make it a prized possession. GEMXX has experienced additional demand throughout India and Asia as the gemstone appeals to a discerning clientele seeking exclusive and collectible pieces.

Gold

GEMXX Corporation’s expansion into the mining of gold reserves in Canada is a new and welcomed asset to the Company’s balance sheet. Gold adds considerable support to the Company’s “Mine-to-Market” business model in three core elements affecting long-term sustainable profitability:

First, the Company can cut its raw material costs by roughly 60% by mining its own gold for its jewelry segment. These cost savings will not only reduce the cost of goods, but the savings will also be reflected in higher and predictable profit margins.

Second, with effective mining of the gold reserves, GEMXX will be able to accumulate reserves for future funding needs for the Company. Therefore, avoiding additional dilutive fundraising by issuing stock or taking on debt to fund the Company.

Third, investors will be able to participate in a stock based on precious metals and gemstones. With the price of gold today at approx. USD $2,000 per ounce, the future looks promising for gold as it is projected to reach new highs in the coming 24 months. Furthermore, as global economic uncertainties persist, investors are turning to traditional safe-haven assets, particularly gold.

GEMXX Corporation's diversified portfolio, including its gold-related ventures, positions the Company to benefit from the ongoing appreciation in gold prices. "We are excited about the tremendous potential for growth in both the ammolite and gold markets," said Richard Clowater, President of GEMXX Corporation. "Our commitment to quality, craftsmanship and our ability to adapt to market dynamics position us for sustained success. We are confident we will be able to deliver strong returns to our shareholders," further stated Clowater.

GEMXX Corporation's financial outlook aligns with these positive market trends, and the Company remains focused on expanding its product offerings, enhancing operational efficiency, and exploring strategic partnerships to maximize shareholder value.

Investors and stakeholders are encouraged to stay updated on GEMXX Corporation's performance as it navigates the evolving landscape of the jewelry and precious metals industry.

ABOUT GEMXX CORPORATION

GEMXX Corporation (OTC: GEMZ; $GEMZ) is a publicly traded, mine-to-market gold, gemstone and jewelry producer with global reach that owns mining resources, production facilities and operating assets. GEMXX controls each stage of its production including gold mining, gemstone production, jewelry manufacturing and global distribution.

GEMXX is a leading producer of top-quality finished ammolite and ammolite jewelry. The Company’s world-class gemstone cutters and jewelry designers are continuously leading the ammolite industry in new and exciting directions. Our management team is made up of the industry's leading experts with a combined total of 160 years of ammolite gemstone and jewelry business experience.

For more information, please visit: GEMXX Corporation

SAFE HARBOR STATEMENT

This press release contains forward-looking statements that can be identified by terminology such as "believes," "expects," "potential," "plans," "suggests," "may," "should," "could," "intends," or similar expressions. Many forward-looking statements involve known and unknown risks, uncertainties, and other factors that may cause actual results to be materially different from any future results implied by such statements. These factors include but are not limited to, our ability to continue to enhance our products and systems to address industry changes, our ability to expand our customer base and retain existing customers, our ability to effectively compete in our market segment, the lack of public information on our Company, our ability to raise sufficient capital to fund our business, operations, our ability to continue as a going concern, and a limited public market for our common stock, among other risks. Many factors are difficult to predict accurately and are generally beyond the Company's control. Forward-looking statements speak only as to the date they are made, and we do not undertake to update forward-looking statements to reflect circumstances or events that occur after the date the forward-looking statements are made.

Signed. /S/ Jay Maull, CEO

GEMXX Corporation

For more information, please contact:
Corporate Communications:
Investor Brand Network (IBN)
Los Angeles, California
www.InvestorBrandNetwork.com
310.299.1717 Office
[e-mail]

[Thehustle]

CEOS Big updates continue/ No dilution

$CEOS the C level staff from https://t.co/w7P06p6830 will be in Vegas this week at the TPE show to wrap up the pre-launch of CONQUER our no-nic pouch brand that we feel will take the industry by storm. Here’s a look at the marketing. We were already on @NEWSMAX talking about it.… pic.twitter.com/BNjWPSti3n

— PsyKey Inc. ($CEOS) (@PsyKeyworld) January 29, 2024

[glenn1919]

ADCT......CVKD......VTAK.......MULN.......https://stockcharts.com/h-sc/ui?s=ADCT&p=D&yr=0&mn=3&dy=0&id=p20089814753&a=1590078240

https://stockcharts.com/h-sc/ui?s=CVKD&p=D&yr=0&mn=3&dy=0&id=p20089814753&a=1590078240
https://stockcharts.com/h-sc/ui?s=VTAK&p=D&yr=0&mn=3&dy=0&id=p20089814753&a=1590078240
https://stockcharts.com/h-sc/ui?s=MULN&p=D&yr=0&mn=3&dy=0&id=p20089814753&a=1590078240

[deri21]

$VTAK Catheter Precision, Inc. (VTAK) Secures New Distributor for VIVO in Turkey
https://www.accesswire.com/827949/catheter-precision-inc-vtak-secures-new-distributor-for-vivo-in-turkey

[glenn1919]

SLNA.....IMCC.......MULN.......https://stockcharts.com/h-sc/ui?s=SLNA

https://stockcharts.com/h-sc/ui?s=IMCC
https://stockcharts.com/h-sc/ui?s=MULN

[trader_ron]

(OTCQB: $XESP)
We engage companies with the common goal of increasing digital interactions within current and new communities to drive growth. From today’s risk takers

Electronic Servitor Publication Network Inc. is a managed services company providing digital activation and engagement solutions to established and developing companies that seek to optimize their digital customer engagement strategies. XESP's managed service offering is powered by a proven, proprietary tech stack - the Digital Engagement Engine (or DE2). This technology provides intelligent interaction management, dynamic content provisioning, and a logic-driven workflow which creates digital experiences that accelerate an audience from awareness to action, no matter what programs and processes that the client already has in place.

[jedijazz]

$CBDW "What a great week for $CBDW, am I right!!!

Our February objective is to continue signing ISOs like
@CannaSiteco
who can deliver instant impact to our bottom line!

It's property #1 moving into February!

With a phenomenal product, "Flying off the shelves", the only place to go from here, is up!

Check out our PR from this AM, and be sure to sign for investor updates at http://cbdw.ai "

https://prnewswire.com/news-releases/1606-corps-ai-chatbot-generates-immediate-revenue-growth-from-new-iso-partnership-302043983.html

#grateful #Shareholders #News #AI #Chatbot

What a great week for $CBDW, am I right!!!

Our February objective is to continue signing ISOs like @CannaSiteco who can deliver instant impact to our bottom line!

It's property #1 moving into February!

With a phenomenal product, "Flying off the shelves", the only place to… pic.twitter.com/YpQszh82DP

— CBDW.ai | A Brand by 1606 Corp (@CBDWInc) January 25, 2024

[glenn1919]

CVKD......VTAK.......ADCT.......MULN......https://stockcharts.com/h-sc/ui?s=CVKD

https://stockcharts.com/h-sc/ui?s=VTAK
https://stockcharts.com/h-sc/ui?s=ADCT
https://stockcharts.com/h-sc/ui?s=MULN

[CK-verse]

$HHSE NEWS: Expanded Release Opportunities Push WILDFIRE Theatrical Launch to April 19

Press Release | 01/25/2024

https://www.otcmarkets.com/stock/HHSE/news/Expanded-Release-Opportunities-Push-WILDFIRE-Theatrical-Launch-to-April-19?id=428374

Favorable response from exhibitors, preview audiences and cross-promotional partners has encouraged indie distributor Hannover House, Inc. (OTC: HHSE) to significantly expand the theatrical release for its first fully-facilitated feature production, "WILDFIRE: The Legend of the Cherokee Ghost Horse." The family-appeal movie was inspired by the # 1 worldwide hit song by Michael Martin Murphey, and features the final big-screen performance for the late Anne Heche.


The film was originally slated for a key market theatrical release on Jan. 26, 2024. However, competitive factors and positive audience response have created the opportunity for a wider theatrical break. The release date of April 19 will provide Hannover House with another three-months of pre-release marketing, as well as place the title in a rare calendar window in which no other family appeal releases are scheduled as competition. There are two other wide release films set for April 19: the Guy Ritchie World War II action film, "The Ministry of Ungentlemanly Warfare" from Lionsgate and "Abigail" a horror-thriller from Universal. There are no live-action family features in the weeks leading up to and following April 19, with only two animated releases set as potential competition for family viewers: Disney's "Luca" on March 22, and Viva's "Dragonkeeper" on April 5.


In addition to traditional in-theatre promotions, Hannover House will also be working with a large assortment of local, regional and national cross-promotional sponsors, ranging from rodeo and horse-riding groups to a major, national retail clothing chain.
"Murphey's 'WILDFIRE' song is so iconic and beloved," said Eric Parkinson. "We have seen how cross-generations react to this movie and to the story of a young girl who befriends a mysterious, wild horse. It's got a great message and is a wholesome, family-appeal movie that leaves you with a smile. The opportunity to fit the movie's release into a window in which there are no competitive family titles was a blessing for the movie and for families that love inspirational films," he continued.


Chevel Shepherd, winner of NBC's "The Voice" competition portrays Samantha Nichols, a young girl who is struggling to deal with the sudden loss of her parents. Michael Martin Murphey portrays Pastor Micah, and Mo Brings Plenty ("Yellowstone") plays Udeli, a Cherokee Spiritual Advisor. The parents are played by Adrian Paul ("Highlander") and Cara Jade Myers ("Killers of the Flower Moon"). Other notable cast members include Olivia Slatton-Fite as Joyce, Thesa Loving as Grandma Bette, Major Dodge Senior as Fred and the late, screen legend Anne Heche as the rodeo trainer.


The film was produced by Snowy Morning, Inc., and shot primarily in eastern Oklahoma, with creative guidance and advisors from the United Keetowah Band of Cherokee Indians. Financing was provided through private investors and through facilitation loans made by Hannover House, in consideration for sales representation rights. Eric Parkinson and Mike Snyder wrote the screenplay and Parkinson directed the film.


In addition to the film's national theatrical release on April 19, 2024 Hannover House is working with Cinemark Theatres for a series of "sneak-peek" / word-of-mouth events to occur on February 28 in selected markets.


TITLE LISTING INFORMATION

Title: WILDFIRE: The Legend of the Cherokee Ghost Horse

Genre: Family / Horses / Live-Action

Writers: Written by ERIC PARKINSON and MIKE SNYDER, based on the hit song by MICHAEL MARTIN MURPHEY

Director: ERIC PARKINSON

Producers: CHRIS LARGE, KYLE MARTENS, ERIC PARKINSON

Stars: CHEVEL SHEPHERD, ANNE HECHE, ADRIAN PAULMICHAEL MARTIN MURPHEY, MO BRINGS PLENTY,OLIVIA SLATTON-FITE, THESA LOVING, MAJOR DODGE, SNR., CASSIE SELF and CARA JADE MYERS.

Director of Photography: ANDREW PARKE

Editor: ANDREW BOWCOCK

Running Time: 111 Minutes
MPAA Rating: Pending (anticipate PG)
Format: 1:185 / Dolby Stereo


For More Information Contact: ERIC PARKINSON, 818-481-5277

[Golden Cross]

$MGRX Is Launching “PRIME”, Powered By KYZATREX Capsules, For An FDA Approved ORAL #Testosterone Replacement Therapy (#TRT) Product!
Link: https://globenewswire.com/news-release/2023/12/13/2795461/0/en/MANGOCEUTICALS-TO-INTRODUCE-PRIME-POWERED-BY-KYZATREX-%ef%b8%8f-CIII-TESTOSTERONE-UNDECANOATE-CAPSULES-FOR-AN-FDA-APPROVED-ORAL-TESTOSTERONE-REPLACEMENT-THERAPY-TRT-PRODUCT.html

The Dallas Based, Direct-to-Consumer Telemedicine Company Secures Marketing Agreement with Marius Pharmaceuticals Bringing KYZATREX to the Telehealth Market as ‘Prime’ by MangoRx

Dallas, Texas & Raleigh, NC, Dec. 13, 2023 (GLOBE NEWSWIRE) -- Mangoceuticals, Inc. (NASDAQ: MGRX) (“MangoRx” or the “Company”), a company focused on developing, marketing, and selling a variety of men’s health and wellness products via a secure telemedicine platform, including its uniquely formulated hair growth product (‘GROW’) and erectile dysfunction (ED) drug (‘Mango’), is excited to announce that it has entered into a Marketing Agreement with Marius Pharmaceuticals ("Marius") to market and sell KYZATREX®️, an innovative FDA-approved oral Testosterone Replacement Therapy (TRT) product, under the program, 'PRIME' by MangoRx.

PRIME will be available on MangoRx’s telemedicine platform with an anticipated launch date of January 31, 2024.

KYZATREX, a prescription drug that is used to treat adult men who have low or no testosterone levels due to certain medical conditions, is one of only three FDA approved TRT treatments that is delivered orally--as opposed to the traditional, invasive, and inconvenient injection-based drug delivery protocol. KYZATREX delivers testosterone in a softgel capsule that is absorbed primarily via the lymphatic system, avoiding liver toxicity.

Testosterone deficiency is often first recognized through symptoms of fatigue or low energy, decreased sex drive, lower muscle mass and many other negative downstream impacts. PRIME, powered by KYZATREX, can help men restore Testosterone to normal levels and improve how they feel. In a 6-month open-label clinical study of 139 hypogonadal patients, 88% of patients taking KYZATREX had normal testosterone levels at Day 90 (worst case scenario (WCS) efficacy calculation, excluding Site 104).1 Among study completers (n=127), 96% of KYZATREX patients achieved normal testosterone levels at Day 90.2 With PRIME, MangoRx will expand broad-based consumer access to this innovative therapy.

TRT treatments have traditionally been delivered through intramuscular needle injection, a subcutaneous implant, or a topical gel. These applications have suffered from different drawbacks depending on the delivery method, such as painful administration, uneven absorption, risk of transfer to others, and disruptions to the body's natural diurnal rhythm allowing for peak performance early in the day.

Twice daily oral TRTs offer painless administration, promote steady absorption, lower SHGB levels, increase free T levels to give the body more usable testosterone, and work with the body's natural diurnal rhythm. Oral softgels are also convenient, mess-free, and discreet.

Shalin Shah, CEO of Marius, shared, “This expansion into telehealth marks an important step in the care of Testosterone Deficient patients. Testosterone Deficiency is a serious chronic disease and has been inadequately addressed by previous generations of products. KYZATREX marks a shift in the treatment paradigm and a meaningful opportunity for patients seeking to restore optimal testosterone levels. Marius is excited to partner with MangoRx as an innovative partner in the DTC marketplace. We look forward to the Mango team bringing more awareness around the significance of Testosterone as a metabolic hormone and its role in optimal health for men with Low T.”

PRIME by MangoRx will bring KYZATREX to patients spanning 48 states through the Company’s telemedicine platform, which is optimized to deliver a smooth medical prescription process, including blood work and synchronous telehealth visits with a fully licensed prescribing physician. Orders will be reviewed and, pending approval, fulfilled, then discreetly shipped via MangoRx’s URAC accredited mail order partner pharmacy directly to the patient’s doorstep.

Jacob Cohen, MangoRx’s Co-Founder and CEO, noted, “PRIME represents a critical expansion into a new vertical with massive market potential and very little competition on the consumer side, while remaining completely consistent with our established identity as a company committed to providing new and innovative pharmaceutical based solutions helping men achieve optimal performance in all areas of life. We are extremely fortunate to be working with Marius and to be one of only a few companies with access to this innovative product. With our established marketing and telemedicine infrastructure in place, we are ready to hit the ground running and take PRIME to patients in need across the country next month."

Testosterone deficiency affects approximately four in ten men older than 45 years and 30-50% of men with obesity or type 2 diabetes, according to the Endocrine Society.3,4 Between 10% and 40% of men worldwide suffer from low testosterone levels.5

About MangoRx

MangoRx is focused on developing a variety of men's health and wellness products and services via a secure telemedicine platform. To date, the Company has identified men's wellness telemedicine services and products as a growing sector and especially related to the area of erectile dysfunction (ED) and hair growth. Interested consumers can use MangoRx’s telemedicine platform for a smooth experience. Prescription requests will be reviewed by a physician and, if approved, fulfilled and discreetly shipped through MangoRx’s partner compounding pharmacy and right to the patient’s doorstep.

To learn more about MangoRx’s mission and other products, please visit www.MangoRx.com or on social media @Mango.Rx.

About Marius Pharmaceuticals

Marius Pharmaceuticals strives to better the lives of patients by focusing on therapies designed for hypogonadism or Testosterone Deficiency. The company's vision is to holistically improve metabolic health and mitigate significant unnecessary costs to the global healthcare system. For more information, please visit www.mariuspharma.com.

About KYZATREX® (testosterone undecanoate)

KYZATREX is a proprietary softgel oral formulation absorbed primarily via the lymphatic system (meaning it is not toxic to the liver) and indicated in adult males for conditions associated with a deficiency or absence of endogenous testosterone. The safety and efficacy of KYZATREX was demonstrated in a phase 3, multi-center, open-label, six-month study in 155 hypogonadal males between 18 and 65 years of age with documented hypogonadism, as defined by a below normal serum testosterone level (≤281 ng/dL) and at least one sign or symptom of testosterone deficiency. In the efficacy population (n=139), 88 percent of hypogonadal men treated with KYZATREX achieved a mean plasma total testosterone concentration (Cavg) over 24 hours within the normal range (222-800 ng/dL) on the final pharmacokinetic (PK) visit of the study at Day 90 (primary endpoint). Based on exploratory endpoints, patients who received KYZATREX reported improvements in symptoms of low testosterone, including quality of life, energy/fatigue, erectile function, sexual intercourse, and mood. The most common side effect reported in ≥2 percent of KYZATREX patients was increased blood pressure (2.6%). The safety and efficacy of KYZATREX in males less than 18 years old have not been established.

[Covid19freak]

KZIA $0.35 -Phase 3 data imminent for cancer drug expected in early Q1 - market cap at laughable 9 million IF results are positive this low floater going to explode

A completed Phase II study in glioblastoma reported promising signals of clinical activity in 2021, and a pivotal study, GBM AGILE, is completed, with final data expected in first half of CY2024. Other clinical trials are ongoing in brain metastases, DMGs, and primary CNS lymphoma, with several of these having reported encouraging interim data.

[OmahaBlue32]

$ICU hot all week!!!

[glenn1919]

VTAK.....CVKD......MRAI......TAOP......MULN.......https://stockcharts.com/h-sc/ui?s=MULN&p=D&yr=0&mn=3&dy=0&id=p11960084343

https://stockcharts.com/h-sc/ui?s=TAOP&p=D&yr=0&mn=3&dy=0&id=p11960084343
https://stockcharts.com/h-sc/ui?s=MRAI&p=D&yr=0&mn=3&dy=0&id=p11960084343
https://stockcharts.com/h-sc/ui?s=CVKD&p=D&yr=0&mn=3&dy=0&id=p11960084343
https://stockcharts.com/h-sc/ui?s=VTAK&p=D&yr=0&mn=3&dy=0&id=p11960084343

[CK-verse]

HHSE-NEWS:..Terrific-Action on WILDFIRE and other Hannover-House Ventures

Saturday, January 20, 2024

http://hannoverhousemovies.blogspot.com/2024/01/terrific-action-on-wildfire-and-other.html


Dear HHSE Friends & Followers - We cannot wipe the smiles off the faces of our WILDFIRE post-production team! Our major studio distribution partner provided some sage notes (mostly regarding sound effects and the film's Music edit) - which have proven to be incredibly insightful and helpful in enhancing the dramatic contrasts between scenes and holding the audience in suspense. Although the preview audience in Fort Worth responded enthusiastically to our event of Nov. 2nd (Lone Star Film Festival - opening night GALA feature film), the "new-and-improved" cut and mix of WILDFIRE is quite a positive leap forward.


Also - after our well-received PREMIERE, we were approached by four major Cross-Promotional Sponsors and six of the top USA Exhibition Chains with exciting opportunities to elevate the film to that next level: a wide USA theatre count opening!


Back in October, Hannover House and our distribution partners for WILDFIRE had planned on a theatrical release date of Jan. 26, 2024, and with a respectable - but not jaw dropping - level of theatre support. This plan matched what we thought would be a rather quick path to theatres, and onto Streaming and DVD in short order. However, as the major studios have proven with their cross-promotional sponsors on event level films, having such brand-name sponsors behind the film - as well as nationally known organizations for cross-promotional support - requires greater coordination and time for implementation. Accordingly, we are looking at April 19 as the film's USA theatrical date... and at a much wider screen count than we have ever achieved or thought possible. It's an incredible home run and major achievement for the first movie fully produced through the support and facilitation of Hannover House or any independent production studio.


Over the next few weeks, there will be a handful of "sneak peek" engagements prior to the wide USA release in April. The first "sneaks" are planned for late February. Additionally, the company's international distributor for the movie is scheduling a screening of the final version at the Berlinale' / European Film Market in mid-February.


But otherwise... POSTERS / LOBBY BANNERS / TRAILERS and ads will start being visible (and with increasing momentum) by early March... with a jaw-dropping wide- opening of the film in late April (which most likely will be April 19).


Some HHSE longs have often said that Hannover House is "ONE" big release away from being a major force (and a major entertainment stock). When you combine this enhanced release of WILDFIRE with the company's OTC markets UPLIST (now in motion!) and our MYFLIX launch activities, the momentum will be unstoppable.


More information will be posted here - as well as on the S.E.C. Edgar site - as these long sought-after goals are coming to fruition.


GO HHSE!!

[deri21]

$VTAK Catheter Precision, Inc. (VTAK) Secures New Distributor in Brazil for LockeT
https://finance.yahoo.com/news/catheter-precision-inc-vtak-secures-130000441.html?soc_src=social-sh&soc_trk=tw&tsrc=twtr

[jedijazz]

$CBDW -CEO of @CannaSiteCo"1606 Corp.'s chatbot was developed to help dispensaries and ecommerce brands boost sales conversions and create an easy customer experience — two top priorities of our web design philosophy and process. This partnership complements both companies" #AI $AI $NVDA $AMD

In light of the new partnership with @CannaSiteCo and $CBDW we'd like to introduce our investors to the CEO of CannaSite and our new ISO... Meet Caron Cooper and see what she had to say! https://t.co/VMESidiNLM | #Growthstock pic.twitter.com/pY29Nw9Y8k

— CBDW.ai | A Brand by 1606 Corp (@CBDWInc) January 19, 2024

[AJH92]

$PSRU Update - January 21.

"Dear Valiant Eagle Inc. [OTC PSRU] Shareholders,

Exciting Official Announcement! Our blockbuster "Zelda," featuring Oscar winner Jennifer Lawrence, is set to resume development next quarter! With the proceeds from its upcoming success, we have earmarked it for a buyback. $PSRU"

Dear Valiant Eagle Inc. (OTC:PSRU) Shareholders,
Exciting Official Announcement! Our blockbuster "Zelda," featuring Oscar winner Jennifer Lawrence, is set to resume development next quarter! With the proceeds from its upcoming success, we have earmarked it for a buyback. $PSRU

— Valiant Eagle (@valianteagleinc) January 21, 2024

"Our market cap posted by OTC Markets is $2.2mm. We expect to earn revenues significantly higher from Zelda to buyback shares without the need for a reverse split as some shareholders have asked. $PSRU"

Our market cap posted by OTC Markets is $2.2mm. We expect to earn revenues significantly higher from Zelda to buyback shares without the need for a reverse split as some shareholders have asked. $PSRU

— Valiant Eagle (@valianteagleinc) January 21, 2024

"The dilution, mainly from convertible noteholders, will be swiftly addressed and resolved by the end of this quarter. We only have a single noteholder remaining and expect their note to be satisfied in short order. $PSRU"

The dilution, mainly from convertible noteholders, will be swiftly addressed and resolved by the end of this quarter. We only have a single noteholder remaining and expect their note to be satisfied in short order. $PSRU

— Valiant Eagle (@valianteagleinc) January 21, 2024

"Get ready for the cinematic journey of a lifetime. Stay Tuned for more updates with full details in our Shareholders Letter to be disseminated within the next couple of business days !
#ZeldaMovie #JenniferLawrence #MovieMagic #StayTuned"

Get ready for the cinematic journey of a lifetime—Stay Tuned for more updates with full details in our Shareholders Letter to be disseminated within the next couple of business days ! 🍿✨ #ZeldaMovie #JenniferLawrence #MovieMagic #StayTunedhttps://t.co/g8u3pZDekk

— Valiant Eagle (@valianteagleinc) January 21, 2024

[Xman4]

SPZI: DD

https://www.globenewswire.com/news-release/2024/01/19/2812484/0/en/SPZI-JP-3E-Holdings-Inc-Secures-US-Department-of-Homeland-Security-EB-5-Program-and-Procures-the-Acquisition-of-CIG-International.html

[glenn1919]

WYY........WKEY.........SAVE.........ARMP........MULN.........https://stockcharts.com/h-sc/ui?s=MULN&p=W&b=5&g=0&id=p84354014936

https://stockcharts.com/h-sc/ui?s=ARMP&p=W&b=5&g=0&id=p84354014936
https://stockcharts.com/h-sc/ui?s=SAVE&p=W&b=5&g=0&id=p84354014936
https://stockcharts.com/h-sc/ui?s=WKEY&p=W&b=5&g=0&id=p84354014936
https://stockcharts.com/h-sc/ui?s=WYY&p=W&b=5&g=0&id=p84354014936

[KPIFF-LDDFF]

$LDDFF


Liberty Defense to Host Senior Delegates from Vietnam for Aviation Security Solutions

https://www.newswire.ca/news-releases/liberty-defense-to-host-senior-delegates-from-vietnam-for-aviation-security-solutions-875159437.html


https://www.reddit.com/r/LibertyDefense/s/NIdOnfwamX


“

…is pleased to host a high-level delegation that will be comprised of senior decision-makers from Vietnam, representing the Ministry of Transport (MOT), Ministry of Public Investments (MPI), Civil Aviation Authority of Vietnam (CAAV), Airports Corporation of Vietnam (ACV), the General Department of Vietnam Customs (GDVC), and/or other relevant aviation stakeholders.

This is a US Trade and Development Agency (USTDA)-sponsored reverse trade mission that is organized and led by the Bilateral Chamber, a global membership-based network of international business leadership that establishes strategic connections between the U.S. and their global trading partners to foster growth, educational advancement, and cultural understanding.

The Reverse Trade Mission (RTM) will help advance Vietnam's goals of improving aviation safety and security standards as the country expands its aviation infrastructure to meet expected long-term air traffic demand increases, advance U.S. Government (USG) engagement with Vietnamese aviation stakeholders and help U.S. firms showcase their aviation security equipment and solutions.

As it pertains to Liberty Defense. this RTM is to showcase state-of-the-art U.S technologies and best practices in:

Aviation safety and security Airport checkpoint design Passenger/cargo security screening Liberty's HEXWAVE product, a next generation, walkthrough, contactless threat detection system for concealed non-metallic and metallic objects, uses AI to provide automated decisions to security operators to process people at speed. Liberty is also developing the millimeter wave-based, High-Definition Advanced Imaging Technology (HD-AIT) body scanner and shoe screener technologies to upgrade airport checkpoint screening.

“

• ?This is a US Trade and Development Agency (USTDA)-sponsored reverse trade mission that is organized and led by the Bilateral Chamber, a global membership-based network of international business leadership that establishes strategic connections between the U.S. and their global trading partners to foster growth, educational advancement, and cultural understanding.

[deri21]

$GMER Good Gaming Inc. Announces Official Launch Date for Galactic Acres™ Its First Groundbreaking Mobile App Game Enhanced with Web3 Technology
https://www.globenewswire.com/news-release/2024/01/18/2811541/0/en/Good-Gaming-Inc-Announces-Official-Launch-Date-for-Galactic-Acres-Its-First-Groundbreaking-Mobile-App-Game-Enhanced-with-Web3-Technology.html

[CK-verse]

$HHSE---Audits, Uplist-to-OTCQB, A.I. play, MYFLIX-streaming-service-launch, Wildfire-movie, Belle-Starr-movie, Meltdown-movie, Major stars to be announced, Form-10 & SEC Registration coming, EXPLOSIVE GROWTH in pps (10x to 100x) on tap upon imminent deliverables.

https://hannoverhousemovies.blogspot.com/

https://www.otcmarkets.com/stock/HHSE/news

[Golden Cross]

$BEGI .0023 Blackstar's patents can revolutionize how stocks are traded!

[glenn1919]

WYY........MULN........https://stockcharts.com/h-sc/ui?s=MULN

https://stockcharts.com/h-sc/ui?s=WYY

[OmahaBlue32]

$ARDX gang. Looking strong.

[Zardiw]

$AVXL Chart from #DDAmanda - #1 Stock Screener :

DDAmanda lets you find these early:



Z

[Zardiw]

$XESP Recent Merger .....New AI Ad Tech:

OTCQB: XESP), a digital engagement and AI company, is releasing a series of infomercials that provide a clear and deeper understanding of the capabilities of its Digital Engagement EngineTM (the DE).

Z

[glenn1919]

muln.........................https://www.marketbeat.com/stocks/NASDAQ/MULN/short-interest/

[trader_ron]

$XESP News - Electronic Servitor Publication Network, Inc. Helps Simplify Explanation of Digital Engagement Capabilities and Technology
https://www.otcmarkets.com/stock/XESP/news/Electronic-Servitor-Publication-Network-Inc-Helps-Simplify-Explanation-of-Digital-Engagement-Capabilities-and-Technology?id=426462

[OmahaBlue32]

$ARDX - coming in strong.
Upgraded sales and price
Targets.